Interleukin-10 Downregulates Anti-microbial Peptide Expression in Atopic Dermatitis
Overview
Authors
Affiliations
Recurrent skin infections in extrinsic atopic dermatitis (EAD) may be because of the suppression of anti-microbial peptide (AMP) expression by interleukin (IL)-4 and IL-13. Twenty to thirty percent of AD, however, are classified as intrinsic atopic dermatitis (IAD). They exhibit normal serum IgE levels, no allergen-specific sensitization, and lower levels of IL-4 and IL-13 than EAD. Both forms of AD have increased propensity to skin infection, suggesting a novel mechanism for infection in IAD. In this study, we observed significantly decreased human beta-defensin (HBD)-2 gene expression in the skin of both IAD (p = 0.010) and EAD (p = 0.004), as compared with psoriasis patients. Conversely, IAD (p = 0.019) and EAD (p = 0.002) skin lesions exhibited elevated IL-10 gene expression when compared with psoriasis. Using primary keratinocytes, we found that the deficiency in AMP expression is an acquired rather than a constitutive defect. Interestingly, neutralizing antibodies to IL-10 augmented the production of tumor necrosis factor-alpha and interferon-gamma by peripheral blood mononuclear cell from AD patients. Additionally, treatment of AD skin explants with anti-IL-10 augmented the expression of both HBD-2 and LL-37. Thus, increased levels of IL-10 may contribute to the AMP deficiency in both IAD and EAD by reducing cytokines that induce AMP.
Gavrilita E, Silion S, Bitca M, Tatu A Clin Cosmet Investig Dermatol. 2024; 17:1377-1386.
PMID: 38881699 PMC: 11179656. DOI: 10.2147/CCID.S459096.
Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis.
Szabo L, Kapitany A, Somogyi O, Alhafez I, Gaspar K, Palatka R Acta Derm Venereol. 2023; 103:adv9413.
PMID: 37387475 PMC: 10326740. DOI: 10.2340/actadv.v103.9413.
Hawerkamp H, Fahy C, Fallon P, Schwartz C Skin Health Dis. 2022; 2(2):e99.
PMID: 35677926 PMC: 9168024. DOI: 10.1002/ski2.99.
Optimizing emollient therapy for skin barrier repair in atopic dermatitis.
Elias P Ann Allergy Asthma Immunol. 2022; 128(5):505-511.
PMID: 35065300 PMC: 9979622. DOI: 10.1016/j.anai.2022.01.012.
Atopic dermatitis: molecular, cellular, and clinical aspects.
Salimian J, Salehi Z, Ahmadi A, Emamvirdizadeh A, Davoudi S, Karimi M Mol Biol Rep. 2022; 49(4):3333-3348.
PMID: 34989960 DOI: 10.1007/s11033-021-07081-7.